Try our Advanced Search for more refined results

September 07, 2018

BioDelivery Sciences International, Inc. et al v. Alvogen Pb Research & Development LLC et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 20, 2021

    Del. Judge Upholds Claims In Opioid Drug IP But Axes Others

    A Delaware federal judge on Monday upheld claims in two patents that BioDelivery Sciences International Inc. accused Alvogen PB Research and Development LLC of infringing with a planned generic of the opioid pain medication Belbuca, but invalidated claims in a third.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!